The gut microbiome drives metabolic rate

Short-chain fatty acids (SCFAs) produced by gut bacteria regulate energy expenditure, fat storage signaling, and appetite hormones (GLP-1, PYY). People with obesity consistently show reduced microbial diversity and depleted SCFA producers. This isn't a cause-and-effect the industry talks about clearly — but the data across 23,000+ microbiome profiles is consistent: metabolic dysbiosis is a real, addressable contributor to weight dysregulation.

Two strains with the strongest metabolic human data: Bifidobacterium animalis subsp. lactis (published reductions in adiposity and improved lipid profiles in controlled trials) and Streptococcus thermophilus (lactase production and energy substrate metabolism). A synbiotic pairing both — with flaxseed prebiotic to drive SCFA output — creates a meaningful metabolic intervention.

What targeted beats generic here

Generic probiotics added to the gut without a prebiotic substrate typically fail to colonize in a dysbiotic metabolic gut — the existing microbiome is too entrenched. A synbiotic gives the therapeutic strains a competitive advantage by including their preferred substrate. The prebiotic makes the synbiotic stick.

GoodOnes™ Fundamentals — Powered by Flore Clinical
The Lean One

A targeted synbiotic — one job, one bottle, strain-specific. No filler strains. No generic kitchen-sink formula.

One metabolic job, 30 days

The Lean One delivers B. animalis subsp. lactis + S. thermophilus (4B CFU each) on the universal Precision core, with flaxseed prebiotic to sustain SCFA production. This is a metabolic synbiotic — not a weight-loss pill with a probiotic label.